Nucleotide and nucleoside-based drugs: past, present, and future
Nucleotide and nucleoside-based analogue drugs are widely used for the treatment of both acute and chronic viral infections. These drugs inhibit viral replication due to one or more distinct mechanisms. It modifies the virus's genetic structure by reducing viral capacity in every replication cy...
Main Author: | Ahmed Abdullah Al Awadh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Saudi Journal of Biological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319562X22003977 |
Similar Items
-
Comparison of the Old and New - Novel Mechanisms of Action for Anti-coronavirus Nucleoside Analogues
by: Joy E. Thames, et al.
Published: (2022-05-01) -
Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors
by: Shenghua Gao, et al.
Published: (2022-12-01) -
Recent advancements in the discovery of small-molecule non-nucleoside inhibitors targeting SARS-CoV-2 RdRp
by: Bangdi Zhou, et al.
Published: (2024-02-01) -
Chikungunya virus nsP4 RNA-dependent RNA polymerase core domain displays detergent-sensitive primer extension and terminal adenylyltransferase activities
by: Chen, Ming Wei, et al.
Published: (2017) -
Structural Investigations on Novel Non-Nucleoside Inhibitors of Human Norovirus Polymerase
by: Gilda Giancotti, et al.
Published: (2022-12-01)